← Evidence map

ReviewESMO open2026

Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape.

F Gay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41819747